Procaps Group SANASDAQ:PROC
- LAST PRICE2.7271
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots2.3500/ 10
- Ask / Lots2.9300/ 10
- Open / Previous Close0.0000 / 2.7271
- Day Range---
- 52 Week Range
- Volume33
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Time | Volume | PROC |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Procaps Group SA | 307.7M | 5.2x | --- |
SNDL Inc | 523.6M | -4.3x | --- |
Bavarian Nordic A/S | 1.7B | 7.6x | --- |
Innoviva Inc | 964.8M | 6.8x | -9.89% |
China BCT Pharmacy Group Inc | 3.8K | 0.0x | --- |
LifeVantage Corp | 79.6M | 26.7x | -16.83% |
Company Information
Procaps Group SA is a Luxembourg-based healthcare and pharmaceutical company. The Company develops, manufactures and sells prescription drugs and products that are differentiated by their combinations and pharmaceutical forms, as well as nutritional supplements which include omega 3 fish oils and high-potency clinical compounds. It operates its business through 5 units which are Diabetrics, Farma Procaps, Softi Gel, Vital Care, and Clinical Specialties. Diabetrics provides diabetes solutions. Farma procaps formulates, manufactures and markets branded prescription drugs in Latin America. Softi Gel provides contract drug development and manufacturing services to third party pharmaceutical companies. Vital Care develops, manufactures and markets consumer healthcare products. Clinical Specialties develops, manufactures and markets complex drugs.
Contact Information
- Headquarters
- 9, rue de BitbourgLUXEMBOURG, Luxembourg 1273
- Phone
- ---
- Fax
- ---
Executives
- Executive Chairman of the Board, Founder
- Ruben Minski
- President
- Camilo Camacho
- Chief Executive Officer
- Jose Vieira
- Chief Financial Officer
- Patricio Vargas Munoz
- Vice President - Corporate Finance
- Carlos Piocuda Russo
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $307.7M |
|---|---|
Revenue (TTM) | $414.1M |
Shares Outstanding | 112.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.14 |
EPS | $0.52 |
Book Value | $-0.01 |
P/E Ratio | 5.2x |
Price/Sales (TTM) | 0.7 |
Price/Cash Flow (TTM) | 4.4x |
Operating Margin | 8.15% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
